THERAFLU NIGHTTIME SEVERE COLD & COUGH HOT LIQUID OTC
Generic Name and Formulations:
Acetaminophen 650mg, diphenhydramine HCl 25mg, phenylephrine HCl 10mg; pwd packets; honey lemon infused with chamomile and white tea flavors; contains potassium 10mg, sodium 23mg, phenylalanine 13mg per packet.
Novartis Consumer Health
Indications for THERAFLU NIGHTTIME SEVERE COLD & COUGH HOT LIQUID:
Nasal and sinus congestion, rhinorrhea, cough, sore throat, fever, headache, minor aches and pains.
Dissolve contents of 1 packet into 8oz hot water; sip while hot. Consume entire drink within 10–15mins. Take every 4 hours; max 6 packets/24hrs.
During or within 14 days of MAOIs. Concomitant other acetaminophen or diphenhydramine products.
Hepatic dysfunction. Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist after 2–7 days. Pregnancy. Nursing mothers.
See Contraindications. Hypertensive crisis with MAOIs. Increased risk of hepatotoxicity with ≥3 alcoholic drinks/day; avoid. β-blockers may increase the pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Analgesic + antihistamine + sympathomimetic.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children, hepatotoxicity (overdosage).
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics